Source:http://linkedlifedata.com/resource/pubmed/id/10796503
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-6
|
pubmed:abstractText |
Respiratory syncytial virus (RSV) is a common cause of pneumonia in infants. Ribavirin is the only antiviral therapy available against RSV. The objective of this review was to assess the effects of aerosolized ribavirin for infants with RSV lower respiratory tract infection.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD000181
|
pubmed:dateRevised |
2005-3-23
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract.
|
pubmed:affiliation |
Children's Hospital, MICU, Farley 517, 300 Longwood Avenue, Boston, MA 02115, USA. adrienne.randolph@tch.harvard.edu
|
pubmed:publicationType |
Journal Article,
Review
|